Study to Evaluate the Safety and Efficacy of DR-3001 Versus Placebo in Women With Overactive Bladder

PHASE2CompletedINTERVENTIONAL
Enrollment

800

Participants

Timeline

Start Date

October 31, 2004

Primary Completion Date

December 31, 2006

Study Completion Date

December 31, 2006

Conditions
Urinary Incontinence
Interventions
DRUG

DR-3001a

4mg daily vaginally

DRUG

DR-3001b

6 mg vaginally daily

OTHER

Placebo

Administered vaginally to match experimental arms

Trial Locations (48)

14221

Duramed Investigational Site, Williamsville

17604

Duramed Investigational Site, Lancaster

19114

Duramed Investigational Site, Philadelphia

29425

Duramed Investigational Site, Charleston

30034

Duramed Investigational Site, Decatur

30328

Duramed Research Site, Sandy Springs

32607

Duramed Research Site, Gainesville

33180

Duramed Investigational Site, Aventura

35209

Duramed Investigational Site, Birmingham

35801

Duramed Investigational Site, Huntsville

36608

Duramed Investigational Site, Mobile

37232

Duramed Investigational Site, Nashville

38120

Duramed Investigational Site, Memphis

38305

Duramed Investigational Site, Jackson

39202

Duramed Investigational Site, Jackson

46202

Duramed Investigational Site, Indianapolis

46825

Duramed Investigational Site, Fort Wayne

47130

Duramed Investigational Site, Jeffersonville

47714

Duramed Investigational Site, Evansville

53209

Duramed Investigational Site, Milwaukee

71106

Duramed Investigational Site, Shreveport

72205

Duramed Investigational Site, Little Rock

75234

Duramed Investigational Site, Dallas

76712

Duramed Research Site, Waco

77024

Duramed Research Site, Houston

78229

Duramed Investigational Site, San Antonio

80012

Duramed Investigational Site, Aurora

80220

Duramed Investigational Site, Denver

80909

Duramed Research Site, Colorado Springs

83642

Duramed Investigational Site, Meridian

83705

Duramed Investigational Site, Boise

83712

Duramed Investigational Site, Boise

84124

Duramed Investigational Site, Salt Lake City

85015

Duramed Research Site, Phoenix

85712

Duramed Research Site, Tucson

92108

Duramed Investigational Site, San Diego

Duremed Research Site, San Diego

97210

Duramed Investigational Site, Portland

98105

Duramed Investigational Site, Seattle

98405

Duramed Research Site, Tacoma

06708

Duramed Investigational Site, Waterbury

03756

Duramed Investigational Site, Lebanon

08837

Duramed Investigational Site, Edison

07039

Duramed Investigational Site, Livingston

08057

Duramed Investigational Site, Moorestown

02904

Duramed Investigational Site, Providence

V6T2B5

Duramed Investigational Site, Vancouver

M4N3M5

Duramed Investigational Site, Toronto

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Duramed Research

INDUSTRY